Free Trial
LON:IXI

IXICO (IXI) Share Price, News & Analysis

IXICO logo
GBX 12.50 +0.50 (+4.17%)
As of 08/7/2025 10:23 AM Eastern

About IXICO Stock (LON:IXI)

Key Stats

Today's Range
11.56
12.50
50-Day Range
9.50
13.16
52-Week Range
6.96
15
Volume
14,301 shs
Average Volume
52,239 shs
Market Capitalization
£11.58 million
P/E Ratio
N/A
Dividend Yield
1.27%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IXICO and its competitors with MarketBeat's FREE daily newsletter.

IXI Stock News Headlines

Altucher: Trump’s Great Gain is starting
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.
See More Headlines

IXI Stock Analysis - Frequently Asked Questions

IXICO's stock was trading at GBX 12.50 at the beginning of the year. Since then, IXI stock has increased by 0.0% and is now trading at GBX 12.50.

IXICO plc (LON:IXI) announced its quarterly earnings results on Tuesday, May, 20th. The company reported ($1.11) earnings per share (EPS) for the quarter. IXICO had a negative trailing twelve-month return on equity of 19.14% and a negative net margin of 31.10%.

Shares of IXI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that IXICO investors own include BioNTech (BNTX), Benefitfocus (BNFT), Grayscale Bitcoin Trust ETF (GBTC), Motif Bio (MTFB), Pfizer (PFE), Tesla (TSLA) and VEON (VEON).

Company Calendar

Last Earnings
5/20/2025
Today
8/07/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:IXI
CIK
N/A
Fax
N/A
Employees
89
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (3.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.38
Net Income
-£3.58 million
Net Margins
-31.10%
Pretax Margin
N/A
Return on Equity
-19.14%
Return on Assets
-10.40%

Debt

Debt-to-Equity Ratio
3.32
Current Ratio
2.85
Quick Ratio
4.90

Sales & Book Value

Annual Sales
£11.50 million
Price / Sales
1.01
Cash Flow
GBX 5.56 per share
Price / Cash Flow
2.25
Book Value
GBX 19.57 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
92,668,597
Free Float
N/A
Market Cap
£11.58 million
Optionable
Not Optionable
Beta
0.86
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:IXI) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners